IDT Expands into Europe
News Oct 31, 2007
Integrated DNA Technologies (IDT) has announced further growth to its product range at its wholly-owned European subsidiary IDT, BVBA. This, coupled with an updated Euro based ordering system, is enabling IDT to better serve the broad variety of life science research projects in Europe.
According to Company, it has developed an unparalleled range of products and services placing it as the ‘No. 1’ supplier of custom oligonucleotides in the United States; they are now aiming to repeat this success in Europe.
Bonnie Barney, Senior Vice President European Sales/Global Advertising for IDT commented, “We have put a lot of time and effort into preparing for this exciting move.” She continued, “Europe presents us with the opportunity to further perfect our service offering as well as bring our extensive experience and product range within reach of more researchers.
”IDT have established a wholly-owned European subsidiary (IDT, BVBA) and is developing a new production facility, both situated in Leuven, Belgium. IDT, BVBA has a growing sales and support network; recent appointments covering the UK and mainland Europe.
Massachusetts General Hospital (MGH) researchers have found that extracellular RNA (exRNA) in urine may be a source of biomarkers for the two most common forms of muscular dystrophy, noninvasively providing information about whether therapeutic drugs are having the desired effects on a molecular level.READ MORE
Is there a link between differences in IQ test performance and the activity of certain genes? Researchers have shown that modifications in the structure of a specific gene have a negative impact on individual test performance. This suggests that environmentally-induced epigenetic changes to our genetic material have a greater impact on intelligence than previously thought.